Infrastructure name

    GRIFOLS (Loan under the European Fund for Strategic Investments)


    Key contact

    Contact phone number

    Contact email

    Project/infrastructure description

    Loan under the European Fund for Strategic Investments (EFSI)

    Date funding committed


    Date infrastructure operational

    Total capital cost (Euros)

    € 100,000,000

    Does the 'Total Capital Cost' include other associated costs?

    Current infrastructure status

    Is this entry applicable to another section of this questionnaire?

    Not applicable

    Further information available at:

    With this loan, the EIB is providing long-term finance in support of the company’s R&D investment, mainly focused on finding new applications for plasmatic proteins, including the treatment of Alzheimer’s disease, vascular diseases, cardiovascular surgery and arterial thrombosis. The R&D activities financed will be carried out at existing centres in Europe up to the end of 2016.

Types: Capital Infrastructure
Member States: European Commission
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF